15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
Thammasat University
Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
University of Alberta
Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
University of Alberta
Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
Hokkaido University
Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.
Miyagi Cancer Center Research Institute
Complexity in influenza virus targeted drug design: interaction with human sialidases.
Pf-Imss-Kek-Sbrc, Ibaraki 305-0801, Japan.
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Hokkaido University
Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.
Gifu University
Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Gifu University
Human Neuraminidases: Structures and Stereoselective Inhibitors.
University of Reims Champagne
Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.
University of Alberta
Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
University of California-Davis